Shares of VanEck Vectors Biotech ETF (NASDAQ:BBH) saw unusually-strong trading volume on Thursday . Approximately 14,251 shares changed hands during mid-day trading, a decline of 32% from the previous session’s volume of 20,907 shares.The stock last traded at $178.63 and had previously closed at $180.26.
The company has a fifty day moving average of $188.11 and a two-hundred day moving average of $199.78.
The company also recently disclosed an annual dividend, which was paid on Monday, December 27th. Investors of record on Tuesday, December 21st were issued a $0.397 dividend. This represents a yield of 0.21%. The ex-dividend date was Monday, December 20th.
A number of hedge funds have recently modified their holdings of the business. Moors & Cabot Inc. acquired a new position in VanEck Vectors Biotech ETF in the third quarter valued at approximately $25,000. Kingsview Wealth Management LLC acquired a new position in VanEck Vectors Biotech ETF in the third quarter valued at approximately $1,003,000. Ironsides Asset Advisors LLC boosted its stake in VanEck Vectors Biotech ETF by 27.6% in the third quarter. Ironsides Asset Advisors LLC now owns 1,940 shares of the company’s stock valued at $392,000 after acquiring an additional 420 shares during the period. Cetera Investment Advisers boosted its stake in VanEck Vectors Biotech ETF by 130.2% in the third quarter. Cetera Investment Advisers now owns 6,358 shares of the company’s stock valued at $1,285,000 after acquiring an additional 3,596 shares during the period. Finally, National Asset Management Inc. acquired a new position in VanEck Vectors Biotech ETF in the third quarter valued at approximately $381,000. Institutional investors own 26.86% of the company’s stock.
About VanEck Vectors Biotech ETF (NASDAQ:BBH)
The BIOTECH HOLDING COMPANY DEPOSITARY RECEIPTS or HOLDRS TRUST was formed under the depositary trust agreement, among The Bank of New York, as trustee, Merrill Lynch, Pierce, Fenner & Smith Incorporated, other depositors and the owners of the Biotech HOLDRS. The trust currently holds shares of common stock or American depositary shares issued by a group of companies that were, at the time of the initial offering, generally considered to be involved in various segments of thebiotechnology industry.
Further Reading: Trading Strategy Methods for Individual Investors
Want More Great Investing Ideas?